Development of T cell immunity to norovirus and rotavirus in children under five years of age.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
01 03 2019
01 03 2019
Historique:
received:
15
11
2018
accepted:
31
01
2019
entrez:
3
3
2019
pubmed:
3
3
2019
medline:
17
9
2020
Statut:
epublish
Résumé
Most of the research effort to understand protective immunity against norovirus (NoV) has focused on humoral immunity, whereas immunity against another major pediatric enteric virus, rotavirus (RV), has been studied more thoroughly. The aim of this study was to investigate development of cell-mediated immunity to NoV in early childhood. Immune responses to NoV GI.3 and GII.4 virus-like particles and RV VP6 were determined in longitudinal blood samples of 10 healthy children from three months to four years of age. Serum IgG antibodies were measured using enzyme-linked immunosorbent assay and production of interferon-gamma by peripheral blood T cells was analyzed by enzyme-linked immunospot assay. NoV-specific T cells were detected in eight of 10 children by the age of four, with some individual variation. T cell responses to NoV GII.4 were higher than those to GI.3, but these responses were generally lower than responses to RV VP6. In contrast to NoV-specific antibodies, T cell responses were transient in nature. No correlation between cell-mediated and antibody responses was observed. NoV exposure induces vigorous T cell responses in children under five years of age, similar to RV. A role of T cells in protection from NoV infection in early childhood warrants further investigation.
Identifiants
pubmed: 30824789
doi: 10.1038/s41598-019-39840-9
pii: 10.1038/s41598-019-39840-9
pmc: PMC6397277
doi:
Substances chimiques
Immunoglobulin G
0
Interferon-gamma
82115-62-6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3199Références
Microbes Infect. 2014 Jun;16(6):472-80
pubmed: 24631874
J Virol. 2010 Feb;84(4):1800-15
pubmed: 20007270
Lancet Infect Dis. 2012 Jul;12(7):561-70
pubmed: 22742639
Arch Virol. 2010 Nov;155(11):1855-8
pubmed: 20721592
Lancet. 2008 Nov 15;372(9651):1746-55
pubmed: 18814906
Science. 2016 Sep 23;353(6306):1387-1393
pubmed: 27562956
Lancet. 1986 Aug 23;2(8504):417-21
pubmed: 2874413
Virology. 2003 Sep 30;314(2):671-9
pubmed: 14554094
J Infect Dis. 2014 Dec 1;210(11):1755-62
pubmed: 24970849
J Infect Dis. 1993 Jun;167(6):1436-40
pubmed: 8388906
J Gen Virol. 1987 Mar;68 ( Pt 3):643-51
pubmed: 3029295
Epidemiol Infect. 2012 Feb;140(2):268-75
pubmed: 21489338
J Virol. 2002 May;76(10):4741-9
pubmed: 11967291
J Virol. 2014 Sep 1;88(17):9728-43
pubmed: 24920797
Curr Opin Pediatr. 2015 Feb;27(1):105-9
pubmed: 25490691
J Infect Dis. 1985 Jan;151(1):99-105
pubmed: 2981278
Clin Ther. 2017 Aug;39(8):1537-1549
pubmed: 28756066
Nat Rev Microbiol. 2007 Jul;5(7):529-39
pubmed: 17571094
Science. 1999 Oct 8;286(5438):287-90
pubmed: 10514371
J Infect Dis. 1992 Jun;165(6):1107-11
pubmed: 1316412
J Infect Dis. 2018 Jan 30;217(4):597-607
pubmed: 29140444
Virology. 2010 Mar 30;399(1):77-86
pubmed: 20096911
Vaccine. 2011 Oct 19;29(45):8126-33
pubmed: 21854823
Proc Biol Sci. 2015 Dec 22;282(1821):20143085
pubmed: 26702035
Infect Genet Evol. 2014 Aug;26:65-71
pubmed: 24837668
Virology. 2007 Jul 5;363(2):410-8
pubmed: 17337285
Clin Diagn Lab Immunol. 2005 Feb;12(2):273-9
pubmed: 15699422
Eur J Pediatr. 2015 Dec;174(12):1679-83
pubmed: 26152345
J Med Virol. 2017 Feb;89(2):239-245
pubmed: 27431308
Viruses. 2012 Jul;4(7):1116-43
pubmed: 22852044
Mol Immunol. 2016 Oct;78:27-37
pubmed: 27573255
Front Microbiol. 2016 Oct 03;7:1570
pubmed: 27752254
PLoS One. 2013 Jul 26;8(7):e70409
pubmed: 23922988
Vaccine. 2006 Apr 5;24(15):2718-31
pubmed: 16446014
Antiviral Res. 2018 Sep;157:1-8
pubmed: 29935205
Virology. 2014 Feb;450-451:106-13
pubmed: 24503072
JCI Insight. 2018 Jul 12;3(13):
pubmed: 29997294
J Virol Methods. 2013 Apr;189(1):228-31
pubmed: 23183143
J Med Virol. 2015 Oct;87(10):1656-61
pubmed: 25946711
Clin Exp Immunol. 2004 Jul;137(1):173-8
pubmed: 15196259
Vaccine. 2018 Aug 28;36(36):5435-5441
pubmed: 28668568
J Infect Dis. 2009 Sep 1;200(5):802-12
pubmed: 19627248
J Virol. 1992 Nov;66(11):6527-32
pubmed: 1328679
J Virol. 2005 May;79(9):5684-94
pubmed: 15827183
J Med Virol. 2011 Mar;83(3):525-31
pubmed: 21264875
Pediatr Infect Dis J. 2018 Jun;37(6):501-505
pubmed: 29135827
Microbes Infect. 2016 Apr;18(4):263-9
pubmed: 26724451
Emerg Microbes Infect. 2017 Apr 12;6(4):e22
pubmed: 28400594
Clin Immunol. 2003 Sep;108(3):241-7
pubmed: 14499247
Clin Vaccine Immunol. 2015 Jun;22(6):656-63
pubmed: 25903355
Curr Opin Virol. 2012 Aug;2(4):419-25
pubmed: 22677178
J Virol. 2005 Apr;79(8):4568-79
pubmed: 15795243
J Virol. 2005 Mar;79(5):2900-9
pubmed: 15709009
Hum Vaccin Immunother. 2013 Sep;9(9):1991-2001
pubmed: 23777748
J Virol. 2019 Feb 19;93(5):
pubmed: 30541855